ReviewMedComm2025

Targeted Therapies in the Most Common Advanced Solid Tumors, Drug Resistance, and Counteracting Progressive Micrometastatic Disease: The Next Frontier of Research.

Andrea Nicolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.